College Dublin (Ireland) today announced the selection for funding of a large-scale European clinical trial of Nilvadipine, an Alzheimer���s disease drug developed at the Roskamp Institute in Sarasota. More than 500 Alzheimer���s patients will...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Alzheimer?s Disease Drug Developed at Roskamp Institute Approved for Key Clinical Trial Funding in Europe
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account